The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients
Open accessAbstract
// A. Marcell Szász 1, 2 , András Lánczky 1 , Ádám Nagy 1 , Susann Förster 3 , Kim Hark 4 , Jeffrey E. Green 4 , Alex Boussioutas 5, 6, 7 , Rita Busuttil 5, 6, 7 , András Szabó 8 , Balázs Győrffy 1, 8 1 MTA-TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary 2 2nd Department of Pathology, Semmelweis University, Budapest, Hungary 3 Max Delbrück Center for Molecular Medicine, Berlin, Germany 4 Transgenic Oncogenesis and Genomics Section, Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda, Maryland, USA 5 Cancer Genetics and Genomics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Australia 6 Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia 7 Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Melbourne, Australia 8 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary Correspondence to: Balázs Győrffy, email: gyorffy.balazs@ttk.mta.hu Keywords: gastric cancer, survival, meta-analysis Received: April 07, 2016 Accepted: June 13, 2016 Published: June 30, 2016 ABSTRACT Introduction: Multiple gene expression based prognostic biomarkers have been repeatedly identified in gastric carcinoma. However, without confirmation in an independent validation study, their clinical utility is limited. Our goal was to establish a robust database enabling the swift validation of previous and future gastric cancer survival biomarker candidates. Results: The entire database incorporates 1,065 gastric carcinoma samples, gene expression data. Out of 29 established markers, higher expression of BECN1 (HR = 0.68, p = 1.5E-05), CASP3 (HR = 0.5, p = 6E-14), COX2 (HR = 0.72, p = 0.0013), CTGF (HR = 0.72, p = 0.00051), CTNNB1 (HR = 0.47, p = 4.3E-15), MET (HR = 0.63, p = 1.3E-05), and SIRT1 (HR = 0.64, p = 2.2E-07) correlated to longer OS. Higher expression of BIRC5 (HR = 1.45, p = 1E-04), CNTN1 (HR = 1.44, p = 3.5E- 05), EGFR (HR = 1.86, p = 8.5E-11), ERCC1 (HR = 1.36, p = 0.0012), HER2 (HR = 1.41, p = 0.00011), MMP2 (HR = 1.78, p = 2.6E-09), PFKB4 (HR = 1.56, p = 3.2E-07), SPHK1 (HR = 1.61, p = 3.1E-06), SP1 (HR = 1.45, p = 1.6E-05), TIMP1 (HR = 1.92, p = 2.2E- 10) and VEGF (HR = 1.53, p = 5.7E-06) were predictive for poor OS. Materials and Methods: We integrated samples of three major cancer research centers (Berlin, Bethesda and Melbourne datasets) and publicly available datasets with available follow-up data to form a single integrated database. Subsequently, we performed a literature search for prognostic markers in gastric carcinomas (PubMed, 2012–2015) and re-validated their findings predicting first progression (FP) and overall survival (OS) using uni- and multivariate Cox proportional hazards regression analysis. Conclusions: The major advantage of our analysis is that we evaluated all genes in the same set of patients thereby making direct comparison of the markers feasible. The best performing genes include BIRC5, CASP3, CTNNB1, TIMP-1, MMP-2, SIRT, and VEGF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Bang, Y.-J., Van Cutsem, E., Feyereislova, A., Chung, H. C., Shen, L., Sawaki, A., Lordick, F., Ohtsu, A., Omuro, Y., Satoh, T., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61121-x · Cited by 7,302
Comprehensive molecular characterization of gastric adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13480 · Cited by 6,498
Győrffy, B., Surowiak, P., Budczies, J., & Lánczky, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082241 · Cited by 1,760
Self-citationHER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
Gravalos, C., & Jimeno, A. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn169 · Cited by 1,184
The Japanese Guidelines for Gastric Cancer Screening
Hamashima, C., Shibuya, D., Yamazaki, H., Inoue, K., Fukao, A., Saito, H., & Sobue, T. (2008) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyn017 · Cited by 403
Boku, N. (2014) · Gastric Cancer · doi:10.1007/s10120-013-0252-z · Cited by 351
Mihály, Z., Kormos, M., Lánczky, A., Dank, M., Budczies, J., Szász, M. A., & Győrffy, B. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2622-y · Cited by 191
Self-citationExpression of DBC1 and SIRT1 Is Associated with Poor Prognosis of Gastric Carcinoma
Cha, E. J., Noh, S. J., Kwon, K. S., Kim, C. Y., Park, B.-H., Park, H. S., Lee, H., Chung, M. J., Kang, M. J., Lee, D. G., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3329 · Cited by 187
He, C.-Z., Zhang, K.-H., Li, Q., Liu, X.-H., Hong, Y., & Lv, N.-H. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-87 · Cited by 161
Molecular pathology of gastric cancer: Research and practice
Yasui, W., Sentani, K., Sakamoto, N., Anami, K., Naito, Y., & Oue, N. (2011) · Pathology - Research and Practice · doi:10.1016/j.prp.2011.09.006 · Cited by 127
Shukla, S., & Gupta, S. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.10168 · Cited by 125
Förster, S., Gretschel, S., Jöns, T., Yashiro, M., & Kemmner, W. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.99 · Cited by 123
Self-citationPeng, Z., Zhu, Y., Wang, Q., Gao, J., Li, Y., Li, Y., Ge, S., & Shen, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084502 · Cited by 111
Catenacci, D. V. T., Henderson, L., Xiao, S., Patel, P. H., Yauch, R. L., Hegde, P. S., Zha, J., Pandita, A., Peterson, A., & Salgia, R. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0175 · Cited by 109
Role of cyclooxygenase-2 in gastric cancer development and progression
Cheng, J., & Fan, X.-M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i42.7361 · Cited by 100
Győrffy, B., Benke, Z., Lánczky, A., Balázs, B., Szállási, Z., Tı́már, J., & Schäfer, R. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1676-y · Cited by 98
Self-citationSurvival after radiotherapy in gastric cancer: Systematic review and meta-analysis
Valentini, V., Cellini, F., Minsky, B. D., Mattiucci, G. C., Balducci, M., D’Agostino, G. R., D’Angelo, E., Dinapoli, N., Nicolotti, N., Valentini, C., et al. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.06.014 · Cited by 98
Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells
Minchenko, О. H., Tsuchihara, K., Minchenko, D. O., Bikfalvi, A., & Esumi, H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i38.13705 · Cited by 97
Sphingosine Kinase 1 and Cancer: A Systematic Review and Meta-Analysis
Zhang, Y., Wang, Y., Wan, Z., Liu, S., Cao, Y. Q., & Zeng, Z. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090362 · Cited by 92
SIRT1 is a regulator of autophagy: Implications in gastric cancer progression and treatment
Qiu, G., Li, X., Che, X., Wei, C., He, S., Lü, J., Jia, Z., Pang, K., & Fan, L. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.05.042 · Cited by 85
SIRT1 Is Downregulated in Gastric Cancer and Leads to G1-phase Arrest via NF-κB/Cyclin D1 Signaling
Yang, Q., Wang, B., Gao, W., Huang, S., Liu, Z., Li, W., & Jia, J. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0214 · Cited by 85
Ali, S. M., Sanford, E. M., Klempner, S. J., Rubinson, D. A., Wang, K., Palma, N. A., Chmielecki, J., Yelensky, R., Palmer, G. A., Morosini, D., et al. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0378 · Cited by 81
c-Met targeting in advanced gastric cancer: An open challenge
Marano, L., Chiari, R., Fabozzi, A., Vita, F. D., Boccardi, V., Roviello, G., Petrioli, R., Marrelli, D., Roviello, F., & Patriti, A. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.05.028 · Cited by 80
Busuttil, R. A., George, J., Tothill, R. W., Ioculano, K., Kowalczyk, A., Mitchell, C., Lade, S., Tan, P. B. O., Haviv, I., & Boussioutas, A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3049 · Cited by 78
Self-citationHe, Y., Zhao, X., Subahan, N. R., Fan, L., Gao, J., & Chen, H. (2014) · Tumor Biology · doi:10.1007/s13277-014-2060-4 · Cited by 77
The prognostic value of serum and immunohistochemical tumour markers in advanced gastric cancer
Webb, A., Scott-Mackie, P., Cunningham, D., et al. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00504-8 · Cited by 72
Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy
Kim, H. K., Choi, I. J., Kim, C. G., Kim, H. S., Oshima, A., Yamada, Y., Arao, T., Nishio, K., Michalowski, A. M., & Green, J. E. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.87 · Cited by 65
Self-citationExpression of SIRT1 in Gastric Cardiac Cancer and Its Clinicopathologic Significance
Feng, A. N., Zhang, L. H., Fan, X., Huang, Q. M., Ye, Q., Wu, H. Y., & Yang, J. (2011) · International Journal of Surgical Pathology · doi:10.1177/1066896911412181 · Cited by 63
Prognostic Value of Survivin in Patients with Gastric Cancer: A Systematic Review with Meta-Analysis
Liu, J. L., Gao, W. Q., Kang, Q. M., Zhang, X. J., & Yang, S. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071930 · Cited by 54
Jørgensen, J. T. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i16.4526 · Cited by 51
Survivin: Potential role in diagnosis, prognosis and targeted therapy of gastric cancer
Wang, T., Qian, X., & Liu, B. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i20.2784 · Cited by 50
Tissue inhibitor of metalloproteinase 1 (TIMP-1) as a biomarker in gastric cancer: a review
Grunnet, M., Mau‐Sørensen, M., & Brünner, N. (2013) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2013.812235 · Cited by 50
Fekete, T., Rásó, E., Pete, I., Tegze, B., Likó, I., Munkácsy, G., Sipos, N., Rigó, J. J., & Győrffy, B. (2011) · International Journal of Cancer · doi:10.1002/ijc.26364 · Cited by 48
Self-citationPrognostic Value of Vascular Endothelial Growth Factor Expression in Resected Gastric Cancer
Liu, L., Ma, X., Xiao, Z., Li, M., Cheng, S.-H., & Wei, Y.-Q. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.7.3089 · Cited by 43
Climent, M., Hidalgo, N. J., Vidal, Ó., Puig, S., Iglesias, M., Cuatrecasas, M., Ramón, J. M., García‐Albéniz, X., Grande, L., & Pera, M. (2015) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2015.08.163 · Cited by 39
[The problem of multiple testing and solutions for genome-wide studies].
Győrffy, B., Györffy, A., & Tulassay, Z. (2005) · PubMed · Cited by 38
Self-citationCyr61/CTGF/Nov family proteins in gastric carcinogenesis
Cheng, T. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i7.1694 · Cited by 34
Friedrichs, B., Siegel, S., Andersen, M. H., Schmitz, N., & Zeis, M. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190500464062 · Cited by 26
Contactin 1: A potential therapeutic target and biomarker in gastric cancer
Chen, D. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i33.9707 · Cited by 25
Cited by
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
Böttcher, J. P., Bonavita, E., Chakravarty, P., Blees, H., Cabeza-Cabrerizo, M., Sammicheli, S., Rogers, N. C., Sahai, E., Zelenay, S., & Reis e Sousa, C. (2018) · Cell · doi:10.1016/j.cell.2018.01.004 · Cited by 1,857
Zhang, J., Liu, H., Hou, L., Wang, G., Zhang, R., Huang, Y., Chen, X., & Zhu, J. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0719-3 · Cited by 517
Siliņa, K., Soltermann, A., Attar, F. M., Casanova, R., Uckeley, Z. M., Thut, H., Wandres, M., Isajevs, S., Cheng, P., Curioni-Fontecedro, A., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1987 · Cited by 448
Xie, M., Yu, T., Jing, X., Ma, L., Fan, Y., Yang, F., Ma, P., Jiang, H., Wu, X., Shu, Y., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01208-3 · Cited by 429
Metadata
- Authors
- Szász, A. M., Lánczky, A., Nagy, Á., Förster, S., Hark, K., Green, J. E., Boussioutas, A., Busuttil, R., Szabó, A., & Győrffy, B.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-06-30
- Volume
- 7
- Issue
- 31
- Pages
- 49322-49333
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2463600666
- Cited by
- 988
- References
- 40
- FWCI
- 110.43
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.